drugset / Trial / NCT02304783

Oral NSAI Versus Paracetamol or Placebo as a Second Line Treatment for Renal Colics

NCT02304783

Phase 3 Completed 1400 enrolled University of Monastir
RandomizedParallel-groupDouble-blindTreatment

Summary

Outpatients treatment with NSAI in renal colics has not been well investigated and there is no clear recommendations regarding this matter. The aim of this study is to determine if an oral NSAI treatment is beneficial in patients discharged for the emergency departement after the first line treatment of a renal colic investigating the recurrence of pain, the reconsultation rates and the admissions.

Timeline

Start
2014-01
Primary completion
2021-06
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 2000 mg
Comparator Piroxicam Unknown 20 mg Oral

Indications

No indication recorded.